CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

Overview

cited authors

Elmas, Ezgi; Saljoughian, Noushin; de Souza Fernandes Pereira, Marcelo; Tullius, Brian P.; Sorathia, Kinnari; Nakkula, Robin J.; Lee, Dean A.; Naeimi Kararoudi, Meisam

authors

Tullius, Brian Patrick, MD

Publication Date

April 5, 2022

webpage

Web of Science

published in

FRONTIERS IN ONCOLOGY Journal

Research

keywords

CAR-NK cell
CAR-T cells
CRISPR
CRISPR screening
NK cells
T cell
immunotherapy
off-target analysis

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.